(Total Views: 51)
Posted On: 01/04/2024 8:06:05 AM
Post# of 27105
$SNGX News Article - Soligenix Announces Top-line Results of the Phase 2a Study of SGX302 (Synthetic Hypericin) in Patients with Mild-to-Moderate Psoriasis https://marketwirenews.com/news-releases/soli...54434.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
